Avita Medical RCEL 深 滬
已收盤 08-07 16:00:00 美东时间
7.77
+3.020
+63.58%
華盛通- 最 高8.07
- 今 開6.01
- 成交量 727.42万股
- 最 低 5.99
- 昨 收 4.75
- 總市值 2.39亿
- 52周最高 8.07
- 市盈率 靜 --
- 換手率 23.64%
- 52周最低 3.22
- 委 比 -92.49%
- 總股本 3077.67万
- 歷史最高 49.11
- 量 比 40.03
- 振 幅 43.79%
- 歷史最低 3.22
- 每 手 1
- 風險率 0.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多This SpaceX Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Ryan Zimmerman upgraded AVITA Medical Inc (NASDAQ:RCEL) from Neutral to Buy and anno...
08-07 20:05
BTIG Upgrades AVITA Medical to Buy, Announces $7 Price Target
BTIG analyst Ryan Zimmerman upgrades AVITA Medical (NASDAQ:RCEL) from Neutral to Buy and announces $7 price target.
08-07 18:12
AVITA Medical Q2 EPS $(0.25) Beats $(0.29) Estimate, Sales $21.702M Beat $20.167M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 34.21 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $21.702 million ...
08-07 04:09
Why ServiceNow Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of ServiceNow Inc (NYSE:NOW) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results. ServiceNow reported quarterly earnings of 90 cents per share, which beat the Street estimate of 85 cents, according to Benzinga Pro data. Quarterly...
07-23 16:35
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
电话会总结 ｜ Avita(RCEL)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据AVITA Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度营收1,930万美元，同比增长4%，环比增长约10%（相比2025年第四季度），为过去一年中最高季度营收。 **盈利能力：** 毛利率81.7%，净亏损1,060万美元（每股亏损0.35美元），较上年同期净亏损1,390万美元（每股亏损0.53美元）有所改善。 **现金状况：** 季度净现金消耗990万美元，期末现金及有价证券余额1,430万美元。 **成本控制：** 运营费用2,450万美元，同比下降11%。 ## 2.
05-16 12:12
Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6
Lake Street analyst Frank Takkinen upgrades AVITA Medical (NASDAQ:RCEL) from Hold to Buy and raises the price target from $3.5 to $6.
05-16 01:44
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
AVITA Medical (NASDAQ:RCEL) released first-quarter financial results and hosted...
05-15 05:26
